New pain block may cut opioid use after breast surgery
NCT ID NCT03599635
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a longer-lasting pain medicine (liposomal bupivacaine) given as a nerve block before breast surgery could reduce the need for opioid painkillers after surgery compared to the standard medicine (bupivacaine). 112 adults having partial mastectomy took part. The goal was to see if the newer medicine provides better pain control and lowers opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M Health Ambulatory Surgery Center
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Your genes may hold the key to predicting Post-Surgical pain
- Unlocking the mystery of persistent pain after breast surgery
- Could a pill replace a needle for emergency pain relief?
- A simple fan could cool away IV needle pain
- Can a smartphone VR headset distract kids from burn pain?